Your browser doesn't support javascript.
loading
[High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells].
Deng, J; Pan, T; Zhou, G; Gao, Y; Peng, W; Wei, W; Lü, C.
Afiliación
  • Deng J; Department of Immunology, School of Basic Medical Sciences; NHC Key Laboratory of Medical Immunology; Center for Human Disease Genomics, Peking University, Beijing 100191, China.
  • Pan T; Hunan Zixing Intelligent Medical Technology Co., Ltd., Changsha 410221, China.
  • Zhou G; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Clinical Research Center for Cancer, Tianjin 300202, China.
  • Gao Y; Department of Breast Surgery, Longgang District Maternity and Child Healthcare Hospital//Longgang Maternity and Child Institute of Shantou University Medical College, Shenzhen 518172, China.
  • Peng W; Hunan Zixing Intelligent Medical Technology Co., Ltd., Changsha 410221, China.
  • Wei W; Hunan Zixing Intelligent Medical Technology Co., Ltd., Changsha 410221, China.
  • Lü C; Department of Oncology, Punan Hospital of Pudong New District, Shanghai 200120, China.
Nan Fang Yi Ke Da Xue Xue Bao ; 43(10): 1657-1664, 2023 Oct 20.
Article en Zh | MEDLINE | ID: mdl-37933640
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Resistencia a Antineoplásicos / Secretogranina II Límite: Humans Idioma: Zh Revista: Nan Fang Yi Ke Da Xue Xue Bao Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Resistencia a Antineoplásicos / Secretogranina II Límite: Humans Idioma: Zh Revista: Nan Fang Yi Ke Da Xue Xue Bao Año: 2023 Tipo del documento: Article País de afiliación: China